These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34861569)

  • 1. "We measure what we can measure": Struggles in defining and evaluating institutional review board quality.
    Lynch HF; Eriksen W; Clapp JT
    Soc Sci Med; 2022 Jan; 292():114614. PubMed ID: 34861569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Of Parachutes and Participant Protection: Moving Beyond Quality to Advance Effective Research Ethics Oversight.
    Lynch HF; Nicholls S; Meyer MN; Taylor HA;
    J Empir Res Hum Res Ethics; 2019 Jul; 14(3):190-196. PubMed ID: 30541368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives of Singaporean biomedical researchers and research support staff on actual and ideal IRB review functions and characteristics: A quantitative analysis.
    Labude MK; Shen L; Zhu Y; Schaefer GO; Ong C; Xafis V
    PLoS One; 2020; 15(12):e0241783. PubMed ID: 33382683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Institutional Review Boards (IRBs) on Clinical Innovation: A Survey of Investigators and IRB Members.
    Stryjewski TP; Kalish BT; Silverman B; Lehmann LS
    J Empir Res Hum Res Ethics; 2015 Dec; 10(5):481-7. PubMed ID: 26564945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is your ethics committee efficient? Using "IRB Metrics" as a self-assessment tool for continuous improvement at the Faculty of Tropical Medicine, Mahidol University, Thailand.
    Adams P; Kaewkungwal J; Limphattharacharoen C; Prakobtham S; Pengsaa K; Khusmith S
    PLoS One; 2014; 9(11):e113356. PubMed ID: 25406085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Operational Characteristics of Institutional Review Boards (IRBs) in the United States.
    Nesom GL; Petrof I; Moore TM
    AJOB Empir Bioeth; 2019; 10(4):276-286. PubMed ID: 31618119
    [No Abstract]   [Full Text] [Related]  

  • 8. Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance.
    Vardeny O; Hernandez AF; Cohen LW; Franklin A; Baqai M; Palmer S; Bierer BE; Cobb N
    Clin Trials; 2019 Jun; 16(3):290-296. PubMed ID: 30866676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding institutional review boards: practical guidance to the IRB review process.
    Pech C; Cob N; Cejka JT
    Nutr Clin Pract; 2007 Dec; 22(6):618-28. PubMed ID: 18042949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs and inconsistencies in US IRB review of low-risk medical education research.
    Kano M; Getrich CM; Romney C; Sussman AL; Williams RL
    Med Educ; 2015 Jun; 49(6):634-7. PubMed ID: 25989411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are central institutional review boards the solution? The National Heart, Lung, and Blood Institute Working Group's report on optimizing the IRB process.
    Mascette AM; Bernard GR; Dimichele D; Goldner JA; Harrington R; Harris PA; Leeds HS; Pearson TA; Ramsey B; Wagner TH
    Acad Med; 2012 Dec; 87(12):1710-4. PubMed ID: 23095928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing the Single IRB Burden: Streamlining Electronic IRB Systems.
    Murray A; Pivovarova E; Klitzman R; Stiles DF; Appelbaum P; Lidz CW
    AJOB Empir Bioeth; 2021; 12(1):33-40. PubMed ID: 32976069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Members of the same club": challenges and decisions faced by US IRBs in identifying and managing conflicts of interest.
    Klitzman R
    PLoS One; 2011; 6(7):e22796. PubMed ID: 21829516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US IRBs confronting research in the developing world.
    Klitzman RL
    Dev World Bioeth; 2012 Aug; 12(2):63-73. PubMed ID: 22515423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Institutional Review Board Quality, Private Equity, and Promoting Ethical Human Subjects Research.
    Lynch HF; Rosenfeld S
    Ann Intern Med; 2020 Oct; 173(7):558-562. PubMed ID: 32687743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local IRBs vs. federal agencies: shifting dynamics, systems, and relationships.
    Klitzman RL
    J Empir Res Hum Res Ethics; 2012 Jul; 7(3):50-62. PubMed ID: 22850143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Do Accredited Organizations Evaluate the Quality and Effectiveness of Their Human Research Protection Programs?
    Fernandez Lynch H; Taylor HA
    AJOB Empir Bioeth; 2023; 14(1):23-37. PubMed ID: 35731960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Real-Time IRB: A Collaborative Innovation to Decrease IRB Review Time.
    Spellecy R; Eve AM; Connors ER; Shaker R; Clark DC
    J Empir Res Hum Res Ethics; 2018 Oct; 13(4):432-437. PubMed ID: 29902956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigators' successful strategies for working with Institutional Review Boards.
    Cartwright JC; Hickman SE; Nelson CA; Knafl KA
    Res Nurs Health; 2013 Oct; 36(5):478-86. PubMed ID: 23813748
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.